Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19

Patients treated recently for a B-lymphoid malignancy are shown to have particularly high risks of severe COVID-19 compared to multiple control cohorts of patients with cancer and COVID-19.

Read the full article here

Related Articles